Michael Vogelbaum, M.D., Ph.D.
| Appointed: |
1999 |
| Gender: |
Male |
| Languages: |
English |
Brain Tumor and Neuro-Oncology Center
Gamma Knife Center
Neurological Surgery
Cancer Biology
Taussig Cancer Institute
Biographical Sketch
Michael A.Vogelbaum, MD, PhD, FACS, has been a member of the professional Staff in the Cleveland Clinic’s Department of Neurological Surgery since 1999. A graduate of the University of Virginia School of Medicine, Charlottesville, Va., he received his specialty training in neurosurgery at the Barnes-Jewish Hospital, St. Louis, Mo. He is board-certified in neurological surgery.
Specializing in the diagnosis and treatment of benign and malignant tumors of the brain and spinal cord, Dr. Vogelbaum also is interested in stereotactic (image-guided) surgery, Gamma Knife therapy and the molecular biology of brain tumors. He has joint appointments with the Cleveland Clinic Gamma Knife Center and the Lerner Research Institute’s Department of Cancer Biology. He is Associate Director of the Brain Tumor and NeuroOncology Center and Director of the Center for Translational Therapeutics at Cleveland Clinic.
In addition to his clinical duties, Dr. Vogelbaum is an active and enthusiastic Research Scientist. He was the recipient of the prestigious American Association of Neurological Surgeons Young Clinician Investigator Award, and receives support and funding from the American Cancer Society, the National Institutes of Health and the Wolf Family Foundation. He and the members of his research laboratory are presently investigating new approaches for the treatment of primary and metastatic brain tumors
Education & Fellowships
| Medical School: | University of Virginia School of Medicine, Charlottesville, VA |
|
| Internship: | Barnes-Jewish Hospital, General Surgery, St. Louis, MO |
| Residency: | Barnes-Jewish Hospital, Neurological Surgery, St. Louis, MO |
| Other Education: | (Doctorate) University of Virginia, Charlottesville, VA |
| Other Education: | (Undergraduate) Johns Hopkins University, Baltimore, MD |
Certifications
Specialty Interests
Benign and malignant tumors of the brain and spinal cord, gamma knife, molecular biology of brain tumors clinical and translational trials, stereotactic surgery, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, gamma knife and radiosurgery, Gamma Knife Radiosurgery, tumors of the brain and spine.
Awards & Honors
- Best Doctors in America, 2006, 2007
- Research funding, Wolf Family Foundation
Professional Memberships
- American Association of Neurological Surgeons
- Congress of Neurological Surgeons
- Society for NeuroOncology
- American Society for Clinical Oncology
- American Association for Cancer Research
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Vogelbaum has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Vogelbaum receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- NeoPharm, Inc.
- Schering-Plough Corporation
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
